United Health Products, Inc. (UEEC)
OTC Markets OTCQB • Currently down 0.00 (-2.63%) in today's trading session
1 member of Congress has disclosed 1 trade in United Health Products, Inc. (UEEC) via STOCK Act filings. The most recent disclosure was a sale by Carlos Curbelo on 19 October 2018. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).
United Health Products, Inc. is currently trading at $0.04, positioned at 9% of its 52-week range ($0.03 – $0.12).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
United Health Products, Inc. Price History and Technical Analysis
Congressional Trading Activity for UEEC
| Carlos Curbelo | 19 Oct 2018 | 6 May 2019 | Sale | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about UEEC
- Which members of Congress have traded UEEC?
- 1 member of Congress has disclosed 1 trade in United Health Products, Inc. (UEEC) under the STOCK Act: Carlos Curbelo.
- When was UEEC most recently disclosed by Congress?
- The most recent UEEC disclosure was a sale by Carlos Curbelo on 19 October 2018.
- What is the total disclosed congressional trading volume for UEEC?
- Members of Congress have disclosed approximately $8K in UEEC sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in UEEC?
- This UEEC page updates as soon as new STOCK Act disclosures are filed for United Health Products, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track UEEC in Congress
See when politicians buy or sell this stock